RSSDI Repository, Complications of Diabetes Demonstration RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

  • Home/
  • Article /
  • Rationale and protocol of the Dapagliflozin And Prevention of Adverse outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial

Rationale and protocol of the Dapagliflozin And Prevention of Adverse outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial

Add to Collection
RCTs HJL Heerspink, BV Stefansson… - Nephrology Dialysis …, 2020 - academic.oup.com

Chapter : Section1
Journal Year : 2020
Cited by : 194.0

… ) and UACR, a disqualifying laboratory test for these variables … to either the diabetic or non-diabetic subpopulation, there is … the trial within the eGFR range classified as Stage 2 CKD. …..... Read More

Keywords : ["chronic kidney disease dapackd randomize control trial", "adverse outcome", "rationale", "protocol", "prevention", "dapagliflozin"]
PubMed Link : https://academic.oup.com/ndt/article-abstract/35/2/274/5728707
Google Scholar Link : https://scholar.google.com/scholar?cites=16835607667203533966&as_sdt=5,44&sciodt=0,44&hl=en&num=20